These structures, if not set up and managed correctly from day one, can create significant accounting, tax and compliance headaches down the road. The post What Life Sciences Companies Get Wrong When Building Cross-Border R&D Structures appeared first on MedCity News .
The future of healthcare depends on enterprises moving decisively beyond the pilot trap by treating enterprise AI as a platform capable of sustaining hundreds of dynamic models. The post Beyond the Pilot Trap: How Healthcare Can Scale AI Without Losing Trust appeared first on MedCity News .
AI documentation tools are genuinely useful. But they are treating a symptom, not the disease. The disease is that physicians have lost control over how they work. The post AI Won’t Fix Physician Burnout — Giving Them More Autonomy Will appeared first on MedCity News .
(MedPage Today) -- Dr. Alexander Wiseman and Dr. Carrie A Schinstock are paid partners of Biogen. In addition, Dr. Schinstock is a principal investigator for ongoing research in AMR and MVI. Each year, approximately 23,000 people in the U.S. are...
(MedPage Today) -- Twannetta Weaver felt like she made the responsible choice when she enrolled in a high-deductible health insurance plan through her employer, an option that avoided high premiums and allowed her to save for retirement. Then...